Comprehensive diagnostic evaluations, including physical exams, imaging studies (CT, MRI, ultrasound), and biopsy procedures, will be performed to accurately diagnose genitourinary cancers. Urine tests and cystoscopy may be used for bladder cancer diagnosis, providing direct visualization and sampling of bladder tissue. Blood tests, including tumor markers specific to genitourinary cancers, can help in diagnosing and monitoring treatment response, particularly in testicular cancer. Genetic and molecular testing of tumors will identify actionable mutations, informing targeted therapy and immunotherapy choices, personalizing the treatment approach. A multidisciplinary team approach ensures comprehensive assessment and care planning, incorporating the expertise of urologists, medical oncologists, radiation oncologists, and surgeons to develop an optimized treatment plan for each patient.